Clinical Trials Logo
  1. Home
  2. Chronic Renal Insufficiency
  3. NCT01846468

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

Chronic Renal Insufficiency Clinical Trial

Official title:
A Partially-blinded, Randomized, Placebo-controlled, Adaptive Single and Multiple Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

Clinical Trial Summary

The purpose of the study is to provide pertinent information to enable decisions regarding the developability of LHW090 for use in patients with chronic renal insufficiency, including a comparison of the potential risk-benefit ratio of several doses of the study drug to enable optimal doses to be tested in later studies.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01846468
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 1
Start date March 1, 2013
Completion date June 28, 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT00968877 - Vitamin D and Chronic Renal Insufficiency Phase 3
Terminated NCT00701714 - Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients Phase 3
Completed NCT00998972 - N-acetyl-cysteine (NAC) and Kidney Graft Function Phase 3
Completed NCT00716573 - Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Phase 4
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT02203084 - Social Determinants in Chronic Disease in British Columbia N/A
Recruiting NCT02147782 - Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Completed NCT01029002 - The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease Phase 3
Completed NCT00742716 - Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease Phase 2
Completed NCT00095056 - An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) Phase 3
Completed NCT00223548 - MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application Phase 2
Completed NCT01574157 - Investigations of the Optimum Serum Bicarbonate Level in Renal Disease. N/A
Active, not recruiting NCT02751099 - Bone and Cardiovascular Disease After Kidney Transplant
Recruiting NCT02002585 - Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease Phase 2
Completed NCT01252810 - Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure Phase 2
Completed NCT01245374 - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents Phase 4
Completed NCT00792857 - Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) Phase 1
Completed NCT00888069 - Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects Phase 1
Completed NCT00369733 - STAAR-3 Clinical Study Phase 4
Recruiting NCT06362759 - A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP Phase 2